AxoGen Statistics
Want to see AXGN full AI Analyst Report?
AxoGen (AXGN) Stock Statistics & Valuation Metrics
Total Valuation
AxoGen has a market cap or net worth of $3.31B. The enterprise value is $2.25B.
- Market Cap
- $3.31B
- Enterprise Value
- $2.25B
Share Statistics
AxoGen has 59,730,717 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,730,717
- Owned by Insiders
- 1.40%
- Owned by Institutions
- 60.71%
Financial Efficiency
AxoGen’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -3.91%.
- Return on Equity (ROE)
- -0.12
- Return on Assets (ROA)
- -0.07
- Return on Invested Capital (ROIC)
- -3.91%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 362.07K
- Profits Per Employee
- -25.25K
- Employee Count
- 622
- Asset Turnover
- 1.02
- Inventory Turnover
- 1.37
Valuation Ratios
The current PE Ratio of AxoGen is -86.05. AxoGen’s PEG ratio is 0.49.
- PE Ratio
- -86.05
- PS Ratio
- 12.52
- PB Ratio
- 6.22
- Price to FCF
- 204.80
- Price to Operating Cash Flow
- 136.31
- PEG Ratio
- 0.49
Income Statement
In the last 12 months, AxoGen had revenue of 225.21M and earned -15.70M in profits. Earnings per share was -0.34.
- Revenue
- 225.21M
- Gross Profit
- 167.35M
- Operating Income
- -7.85M
- Pretax Income
- -15.70M
- Net Income
- -15.70M
- EBITDA
- 192.00K
- Earnings Per Share (EPS)
- -0.34
Cash Flow
In the last 12 months, operating cash flow was 22.63M and capital expenditures -6.32M, giving a free cash flow of 16.31M billion.
- Operating Cash Flow
- 22.63M
- Free Cash Flow
- 16.31M
- Free Cash Flow per Share
- 0.30
Dividends & Yields
AxoGen pays an annual dividend of $1.00, resulting in a dividend yield of ―
- Dividend Per Share
- $1.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.49%
- Earnings Yield
- -1.04%
Stock Price Statistics
- Beta
- 1.19
- 52-Week Price Change
- 132.65%
- 50-Day Moving Average
- 42.95
- 200-Day Moving Average
- 40.43
- Relative Strength Index (RSI)
- 69.94
- Average Volume (3m)
- 1.55M
Important Dates
AxoGen upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- Jan 27, 2010
Financial Position
AxoGen as a current ratio of 5.11, with Debt / Equity ratio of 52.49%
- Current Ratio
- 5.11
- Quick Ratio
- 3.31
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 167.09
- Interest Coverage Ratio
- -1.02
Taxes
In the past 12 months, AxoGen has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
AxoGen EV to EBITDA ratio is -142.47, with an EV/FCF ratio of 185.50.
- EV to Sales
- 11.34
- EV to EBITDA
- -142.47
- EV to Free Cash Flow
- 185.50
- EV to Operating Cash Flow
- 133.70
Balance Sheet
AxoGen has $348.07M in cash and marketable securities with $19.47M in debt, giving a net cash position of $328.60M billion.
- Cash & Marketable Securities
- $348.07M
- Total Debt
- $19.47M
- Net Cash
- $328.60M
- Net Cash Per Share
- $5.50
- Tangible Book Value Per Share
- $8.85
Margins
Gross margin is 74.18%, with operating margin of -5.17%, and net profit margin of -11.96%.
- Gross Margin
- 74.18%
- Operating Margin
- -5.17%
- Pretax Margin
- -11.96%
- Net Profit Margin
- -11.96%
- EBITDA Margin
- -7.96%
- EBIT Margin
- -11.29%
Analyst Forecast
The average price target for AxoGen is $58.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $58.18
- Price Target Upside
- 4.03% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 11
- Revenue Growth Forecast
- 24.32%
- EPS Growth Forecast
- -1274.47%
Scores
- Smart Score
- 10
- AI Score
- 68
